Canada Gazette, Part I, Volume 157, Number 16: GOVERNMENT NOTICES

April 22, 2023


Public notice to inform Canadians of the decisions adopted at the 19th Conference of the Parties to the Convention on International Trade in Endangered Species of wild fauna and flora and of Canada’s intent to implement the decisions domestically

This notice is to inform Canadians of the decisions adopted at the 19th Conference of the Parties (COP19) to the Convention on the International Trade in Endangered Species (CITES) and the intent of the Minister of Environment and Climate Change to implement these decisions in Canada.

CITES was established to help ensure that international trade in specimens of wild animals and plants does not threaten their survival. More than 38 700 species of animals and plants are listed in the three appendices to CITES.

Species listed in Appendix I are considered threatened with extinction and are or may be affected by trade. Generally, these species may not be traded for commercial purposes. However, these species may be traded for non-commercial purposes such as educational, scientific and re-introduction purposes, under strict conditions. These conditions include the prior issuance of import and export permits by the importing and exporting countries, respectively.

Species listed in Appendix II are those that are not considered threatened with extinction, but that may become so if their trade is not regulated. Species may also be listed in Appendix II if they are similar in appearance to Appendix I and Appendix II species, to ensure the protection of the species of concern. Only export permits issued by the exporting country are required for Appendix II species.

Species listed in Appendix III are under special management in a country and are listed unilaterally by that Party in order to receive the assistance of other countries in preventing unauthorized exports. The export of Appendix III species requires either an export permit or a certificate of origin, depending on the circumstances.

The 45 proposals to the CITES appendices that were adopted by COP19 include additions and reclassifications of species listings as well as the addition or modification of annotations and nomenclature. For more information on the decisions adopted by CITES COP19, please refer to the web page Outcomes of species proposals: 19th Conference of the Parties.

Canada implements CITES domestically through the Wild Animal and Plant Protection and Regulation of International and Interprovincial Trade Act and the Wild Animal and Plant Trade Regulations (WAPTR).

The Minister intends to request an exemption from prepublication of amendments to WAPTR in the Canada Gazette, Part I. Final regulatory amendments to WAPTR are currently anticipated to be published in the Canada Gazette, Part II, in fall 2023.

Paula Brand
Acting Director General
Wildlife Management Directorate
Canadian Wildlife Service



Notice of intent to address 65 existing substances identified as Chemicals Management Plan priorities following categorization and other prioritization mechanisms

With the launch of the Chemicals Management Plan (CMP) in 2006, the Government of Canada committed to conducting risk assessments of 4 363 prioritized substances. A total of 4 144 substances have been addressed to date, and an additional 154 are planned to be addressed by March 2024. The purpose of this notice is to articulate how the remaining 65 substances will be addressed as the Government transitions to new priorities and an enhanced assessment program resulting from proposed amendments to the Canadian Environmental Protection Act, 1999 (CEPA).


CEPA mandates that screening assessments be conducted for the substances identified as meeting criteria for the categorization of substances on the Domestic Substances List (DSL), to determine if the substance is toxic or capable of becoming toxic. When the CMP was launched in 2006, one of its program objectives was to address the 4 363 substances identified as priorities at the time of categorization, by 2020. This goal was ambitious considering the number of substances and the complexity of some of the assessment work. Through the course of the CMP, some assessments were further broadened to include related DSL substances in addition to the original priorities, representing more than 200 additional substances. Approximately 330 priority substances remained to be assessed by the end of 2020, and the timeline for completion of this goal was extended to March 2024.

As of March 2023, 4 144 of the 4 363 priority substances (95%) have been addressed in either draft or final reports. Of the remaining 219 substances, 154 are planned to be addressed in draft reports by March 2024, raising the anticipated overall program completion rate to 98.5%. The remaining 65 substances (1.5%) require further consideration to determine the appropriate approach to assessing and, if necessary, managing risks.

Planned actions

The 65 substances (see Annex I) have been placed into two categories to be addressed, as described below:

Category 1: Substances that need further data collection or will be considered as part of an expanded group that is not yet ready for assessment

The substances or groups included in Table 1 may be considered in future assessments. They require further information gathering (e.g. data generation, collection of commercial use information, or environmental monitoring) before assessment can be initiated. Many will be added to larger groups or classes of similar substances for assessment, to allow the Government to better understand and consider the risks of all substances in the group or class, and support efforts to consider cumulative effects. Group or class-based assessments better inform future decisions regarding substitution of toxic substances.

Table 1: Priority substances included in category 1
Substance/Group Number of substances
Quaternary ammonium compounds 19
Alkylbenzene sulfonates and derivatives 19
Benzophenone-12 1
Mineral oils 1
Pharmaceuticals 9
Vetiver oils 2

Category 2: Substances that will be addressed using alternative assessment strategies

As other programs and regulatory frameworks address the health and environmental considerations that may be associated with the substances in Table 2, a screening assessment under CEPA is not needed at this time.

Table 2: Priority substances included in category 2
Substance/Group Number of substances
Ethanol 1
Gasoline substances, diesel substances, crude oil and bitumen 9
Vitamin A and related substances 4

Publication of this notice and associated path forward for the remaining 65 substances will complete reporting against the 2006 commitment to assess the 4 363 prioritized substances, as the Government transitions to a new priority and assessment program.

Information gathering

Pursuant to section 70 of CEPA, should individuals have data or information that reasonably supports the conclusion that any of the above substances is toxic or is capable of becoming toxic, they are required to submit it to the Minister of Environment, unless they have knowledge that either the Minister of Environment or the Minister of Health already has the information.

Contact information

Stakeholders are invited to subscribe to the Chemicals Management Plan subscription service to be kept informed of future activities under CEPA as well as information sessions or consultations.

Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
Environment and Climate Change Canada

Greg Carreau
Director General
Safe Environments Directorate
Health Canada


List of the 65 existing substances identified as CMP priorities following categorization and other prioritization mechanisms

Table columns include CAS RN,footnote 1 Domestic Substances List name and category of planned action.

CAS RN Domestic Substances List name Category
50-48-6 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl- 1
57-09-0 1-Hexadecanaminium, N,N,N-trimethyl-, bromide 1
58-20-8 Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17β)- 1
64-17-5 Ethanol 2
64-86-8 Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 1
68-26-8 Retinol 2
116-31-4 Retinal 2
117-98-6 6-Azulenol, 1,2,3,3a,4,5,6,8a-octahydro-4,8-dimethyl-2-(1-methylethylidene)-, acetate 1
127-68-4 Benzenesulfonic acid, 3-nitro-, sodium salt 1
139-07-1 Benzenemethanaminium, N-dodecyl-N,N-dimethyl-, chloride 1
139-08-2 Benzenemethanaminium, N,N-dimethyl-N-tetradecyl-, chloride 1
315-37-7 Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17β)- 1
1843-05-6 Methanone, [2-hydroxy-4-(octyloxy)phenyl]phenyl- 1
2398-96-1 Carbamothioic acid, methyl(3-methylphenyl)-, O-2-naphthalenyl ester 1
7235-40-7 β,β-Carotene 2
8002-05-9 Petroleum 2
8006-61-9 Gasoline, natural 2
8012-95-1 Paraffin oils 1
9004-66-4 Iron dextran 1
11103-57-4 Vitamin A 2
23593-75-1 1H-Imidazole, 1-[(2-chlorophenyl)diphenylmethyl]- 1
26264-05-1 Benzenesulfonic acid, dodecyl-, compd. with 2-propanamine (1:1) 1
28519-02-0 Benzenesulfonic acid, dodecyl(sulfophenoxy)-, disodium salt 1
61789-77-3 Quaternary ammonium compounds, dicoco alkyldimethyl, chlorides 1
61789-80-8 Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides 1
61789-86-4 Sulfonic acids, petroleum, calcium salts 1
61789-87-5 Sulfonic acids, petroleum, magnesium salts 1
61790-48-5 Sulfonic acids, petroleum, barium salts 1
61791-34-2 Onium compounds, morpholinium, 4-ethyl-4-soya alkyl, Et sulfates 1
64742-80-9 Distillates (petroleum), hydrodesulfurized middle 2
65277-42-1 Piperazine, 1-acetyl-4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, rel- 1
67633-57-2 1H-Imidazolium, 1-ethyl-4,5-dihydro-1-(2-hydroxyethyl)-2-isoheptadecyl-, ethyl sulfate (salt) 1
67774-74-7 Benzene, C10-13-alkyl derivs. 1
68122-86-1 Imidazolium compounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-1-(2-tallow amidoethyl), Me sulfates 1
68153-35-5 Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N’-ditallow acyl derivs., Me sulfates (salts) 1
68308-67-8 Quaternary ammonium compounds, ethyldimethylsoya alkyl, Et sulfates 1
68334-30-5 Fuels, diesel 2
68391-01-5 Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides 1
68391-05-9 Quaternary ammonium compounds, di-C12-18-alkyldimethyl, chlorides 1
68411-30-3 Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts 1
68411-32-5 Benzenesulfonic acid, dodecyl-, branched 1
68424-85-1 Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides 1
68476-34-6 Fuels, diesel, no. 2 2
68511-92-2 9-Octadecenoic acid (Z)-, reaction products with diethylenetriamine, cyclized, di-Et sulfate-quaternized 1
68584-22-5 Benzenesulfonic acid, C10-16-alkyl derivs. 1
68584-24-7 Benzenesulfonic acid, C10-16-alkyl derivs., compds. with 2-propanamine 1
68584-25-8 Benzenesulfonic acid, C10-16-alkyl derivs., compds. with triethanolamine 1
68608-26-4 Sulfonic acids, petroleum, sodium salts 1
68648-87-3 Benzene, C10-16-alkyl derivs. 1
68649-00-3 Benzenesulfonic acid, mono-C9-17-branched alkyl derivs., compds. with 2-propanamine 1
68783-96-0 Sulfonic acids, petroleum, calcium salts, overbased 1
68917-65-7 Terpenes and Terpenoids, vetiver-oil 1
68953-58-2 Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, salts with bentonite 1
70146-13-3 Benzenesulfonic acid, oxybis[decyl-, disodium salt 1
70288-86-7 Ivermectin 1
70775-94-9 Sulfonic acids, C10-18-alkane, Ph esters 1
70955-34-9 Fatty acids, tall-oil, reaction products with 2-[(2-aminoethyl)amino]ethanol, di-Et sulfate-quaternized 1
71011-24-0 Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with bentonite 1
71011-26-2 Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, chlorides, compds. with hectorite 1
72102-40-0 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-lanolin acyl derivs., Et sulfates 1
86290-81-5 Gasoline 2
90218-35-2 Benzenesulfonic acid, dodecyl-, branched, compd. with 2-propanamine 1
128683-24-9 Bitumens 2
128683-25-0 Crude oil (oil sand) 2
101316-57-8 Distillates (petroleum), hydrodesulfurized full-range middle 2



Guidelines for Canadian Recreational Water Quality – Microbiological sampling and analysis

Pursuant to subsection 55(3) of the Canadian Environmental Protection Act, 1999, the Minister of Health hereby gives notice of the Guidelines for Canadian Recreational Water Quality – Microbiological sampling and analysis. The proposed technical document for these guidelines is available from April 21, 2023, to June 20, 2023, on the Health Canada Environment and workplace health consultations web page. Any person may file written comments on the proposed document with the Minister of Health within 60 days after publication of this notice. Comments must be sent by email to

April 21, 2023

Greg Carreau
Director General
Safe Environments Directorate
On behalf of the Minister of Health



The Guidelines for Canadian Recreational Water Quality consist of multiple guideline technical documents that consider the various factors that could interfere with the safety of recreational waters from a human health perspective. This includes technical documents on understanding and managing risks in recreational waters; fecal indicator organisms; microbiological sampling and analysis; cyanobacteria and their toxins; physical, aesthetic and chemical characteristics; and microbiological pathogens and other biological hazards. These documents provide guideline values for specific parameters used to monitor water quality hazards and recommend science-based risk management strategies.

Recreational waters are any natural fresh, marine or estuarine bodies of water that are used for recreational purposes; this includes lakes, rivers and human-made systems (e.g. stormwater ponds, artificial lakes) that are filled with untreated natural waters. Jurisdictions may choose to apply these guidelines to other natural waters for which limited treatment is applied (e.g. short-term use of disinfection for an athletic event). Applying the guidelines in these scenarios should be done with caution. Some disease-causing microorganisms (e.g. protozoan pathogens) are more difficult to disinfect than fecal indicator organisms and may still be present even if disinfection has reduced the fecal indicators to acceptable levels.

Recreational water activities that could present a human health risk through intentional or incidental immersion and ingestion include primary contact activities (e.g. swimming, wading, windsurfing and waterskiing) and secondary contact activities (e.g. canoeing, boating and fishing).

Each guideline technical document has been established based on current, published scientific research related to health effects, aesthetics and beach management considerations. The responsibility for recreational water quality generally falls under provincial and territorial jurisdiction, so the policies and approaches, as well as the resulting management decisions, may vary between jurisdictions. The guideline technical documents are intended to inform decisions by provincial, territorial and local authorities that are responsible for the management of recreational waters.

This document includes information on sampling and analysis for microbiological parameters.

Overview of microbiological sampling and analysis

Monitoring of recreational water quality is an important component of a preventive risk management approach. Its main functions are to characterize water quality, confirm the effectiveness of risk management activities already in place and guide future mitigation actions. Having a well-structured and well-planned monitoring program for recreational water areas is essential for managers and authorities to assess risks, inform public health decisions and communicate water quality information to the public. The priority microbiological hazards for most areas are fecal wastes that are introduced into the water by humans and animals, and harmful cyanobacterial blooms.

Routine water sampling and analysis for the primary indicators of fecal contamination—Escherichia coli (E. coli, fresh water) and enterococci (marine and fresh water)—is used to inform day-to-day management decisions (e.g. the issuing of swimming advisories) and for determining the overall suitability of an area for recreational water use. Additional data collected during on-site investigations (e.g. environmental conditions, area activities) provide support for interpreting and predicting water quality results. Other fecal indicators can be included in monitoring programs or used in source-tracking studies to provide further information on the sources of fecal contamination that helps refine potential health risks. Sampling and analysis of sand and sediments may also be conducted during investigations, as it is known that these matrices can harbour microorganisms, including fecal indicators and pathogens, from fecal matter and other environmental sources. The use of standard procedures for the collection, transport and analysis of samples is critical to obtain the most accurate assessment of water quality. Standardized culture-based and polymerase chain reaction–based methods for the quantification of fecal indicators are available. However, the choice of analytical methods will depend on factors such as monitoring program requirements, laboratory capability and capacity, beach-specific considerations (e.g. source water characteristics) and jurisdictional requirements.

Pathogenic microorganisms (i.e. pathogenic bacteria, protozoa, viruses and fungi) may be present in recreational waters. Routine monitoring for these microorganisms is not recommended, due to the complexity and costs associated with analysis. Testing for specific pathogens may be conducted for investigative purposes, for example, in response to an outbreak of waterborne illness. Primary indicators of fecal contamination are used to show the potential presence of fecal pathogens. Microbial source tracking information can also aid in interpreting fecal indicator results.

Cyanobacteria blooms are also a significant hazard for some recreational water bodies. Information on parameters and monitoring methods used in cyanobacterial management plans can be found in the technical documents on cyanobacteria and their toxins developed for the Guidelines for Canadian Recreational Water Quality and the Guidelines for Canadian Drinking Water Quality. Different methods and techniques are used to collect samples for cyanobacterial identification or for toxin analysis.




April 14, 2023

Rachida Lagmiri
Official Documents Registrar


Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.

Governor in Council appointment opportunities
Position Organization Closing date
Director Asia-Pacific Foundation of Canada  
Director Atomic Energy of Canada Limited  
Director Bank of Canada  
Chairperson Business Development Bank of Canada  
Director Business Development Bank of Canada  
Director Canada Council for the Arts  
Director Canada Deposit Insurance Corporation  
Director Canada Foundation for Sustainable Development Technology  
Director Canada Post Corporation  
Director Canada Revenue Agency  
Director Canadian Commercial Corporation  
Member Canadian Cultural Property Export Review Board  
Director Canadian Energy Regulator  
Chief Commissioner Canadian Grain Commission  
Chief Commissioner Canadian Human Rights Commission  
Pay Equity Commissioner Canadian Human Rights Commission  
Member Canadian Human Rights Tribunal  
Member Canadian Institutes of Health Research  
President Canadian Institutes of Health Research  
Member Canadian International Trade Tribunal  
Trustee Canadian Museum of Immigration at Pier 21  
Permanent Member Canadian Nuclear Safety Commission  
President Canadian Nuclear Safety Commission  
Member Canadian Radio-television and Telecommunications Commission  
Member Canadian Statistics Advisory Council  
Director Canadian Tourism Commission  
Chairperson Canadian Transportation Accident Investigation and Safety Board  
Member Canadian Transportation Accident Investigation and Safety Board  
Member Canadian Transportation Agency  
Director Export Development Canada  
Director First Nations Financial Management Board  
Commissioner First Nations Tax Commission  
Deputy Administrator Fund for Railway Accidents Involving Designated Goods  
Member Historic Sites and Monuments Board of Canada  
Commissioner International Commission on the Conservation of Atlantic Tunas  
President International Development Research Centre  
Commissioner International Joint Commission  
Chairperson Military Grievances External Review Committee  
Vice-Chairperson Military Grievances External Review Committee  
Chairperson National Advisory Council on Poverty  
Member National Advisory Council on Poverty  
Member (Children’s Issues) National Advisory Council on Poverty  
Commissioner National Battlefields Commission  
Chairperson National Capital Commission  
Member National Capital Commission  
Member National Farm Products Council  
Vice-Chairperson National Farm Products Council  
Director National Gallery of Canada  
Member Net-Zero Advisory Body  
Canadian Representative North Atlantic Salmon Conservation Organization  
Canadian Representative North Pacific Anadromous Fish Commission  
Conflict of Interest and Ethics Commissioner Office of the Conflict of Interest and Ethics Commissioner  
Public Sector Integrity Commissioner Office of the Public Sector Integrity Commissioner  
Member Pacific Pilotage Authority  
Member Patented Medicine Prices Review Board  
Vice-Chairperson Patented Medicine Prices Review Board  
Commissioner Public Service Commission  
President Public Service Commission  
Principal Royal Military College of Canada  
Deputy Administrator Ship-source Oil Pollution Fund  
Member Standards Council of Canada  
Chief Executive Officer VIA Rail Canada Inc.  
Chief Executive Officer Windsor-Detroit Bridge Authority